+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotypic HIV-1 resistance correlates with treatment outcome of nelfinavir salvage therapy



Phenotypic HIV-1 resistance correlates with treatment outcome of nelfinavir salvage therapy



Antiviral Therapy 5(4): 249-256



In order to analyse whether drug sensitivity testing would be beneficial for clinical decision-making in heavily pretreated patients, we retrospectively studied viral genotype and phenotypic drug resistance in 12 HIV-1-infected patients, each of them with a history of failing at least one therapeutic regimen including one or two protease inhibitors (PIs). The salvage therapy included nelfinavir as new PI in all cases. Four patients showed a sustained and five patients a transient viral load decrease. Three patients failed to show a significant decline of plasma HIV-1 RNA. In the baseline samples of these cases, resistance against all components of their combination therapy could be detected, whereas at least one antiretroviral drug was still active in the cases with transient treatment response. All patients with sustained therapy response harboured viruses that were either fully sensitive or resistant to only one of the drugs administered. In our study, phenotypic drug resistance was predictive for the success of antiretroviral salvage regimens.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046973769

Download citation: RISBibTeXText

PMID: 11142619


Related references

Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine. Antiviral Therapy 5(3): 187-194, 2000

Early CD4, viral load, and quality of life response to salvage treatment with nelfinavir The UCSD Owen Clinic Nelfinavir Expanded Access Experience. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 37: 279, 1997

Phenotypic cross-resistance to nelfinavir: the role of prior antiretroviral therapy and the number of mutations in the protease gene. Aids Research and Human Retroviruses 17(3): 211-215, 2001

Nelfinavir plus nevirapine plus two NRTIS as salvage therapy for HIV-infected patients receiving long-term antiretroviral treatment. HIV Clinical Trials 2(1): 1-5, 2001

Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy. Aids Research and Human Retroviruses 17(15): 1379-1385, 2001

Impact of HIV-1 drug-resistance mutations and phenotypic resistance profile on virologic response to salvage therapy in an observational cohort. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 306, 2000

Dual nelfinavir /saquinavir soft gel gelatin capsule protease inhibitor treatment in a quadruple drug BID regimen as salvage therapy in advanced HIV disease. AIDS 12(Suppl. 4): S39, 1998

Virologic response of nine therapy-experienced children receiving 64 weeks of nelfinavir salvage therapy. Annals of the new York Academy of Sciences 918: 381-385, 2000

Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrations. Therapeutic Drug Monitoring 25(1): 73-80, 2003

Salvage therapy using a nelfinavir- and nevirapine-containing regimen. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 426-427, 1998

Lopinavir/r versus nelfinavir as salvage therapy. Pediatric Infectious Disease Journal 24(4): 392-393, 2005

Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy. European Journal of Medical Research 4(2): 54-58, 1999

Survival outcome by early chemoradiation therapy salvage or early surgical salvage for the treatment of hypopharyngeal cancer. Otolaryngology--Head and Neck Surgery 137(5): 711-716, 2007

Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review. World Journal of Urology 31(2): 403-409, 2013

Predictive value of genotypic and phenotypic resistance in 2 nelfinavir-experienced patients. Journal of Infectious Diseases 181(5): 1862-1864, 2000